Author

Can Shen

Yunnan University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Jinghua LiuiD· 2 shared Ting Wan· 2 shared Yahui Li· 2 shared Jun Tian WuiD· 1 shared Kai Fu· 1 shared Keqin Wang· 1 shared Ling Yang· 1 shared Ruoxue Yang· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

Jinghua LiuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Platelets promote acute liver injury via extracellular vesicles-mediated Aldolase A

Ruoxue Yang, Jinghua Liu, Kai Fu, Ting Wan, Yahui Li, Can Shen, Ling Yang, Keqin Wang, Zhao Shan

This study shows platelets worsen acute liver injury by transferring aldolase A via extracellular vesicles to Kupffer cells, promoting inflammation and injury.

bioRxiv · Sep 14, 2026 · PreprintPathology

HSF4: A Prognostic Predictor and Potential Therapeutic Target in Colorectal Cancer with Implications for Patient Immune Status

Ting Wan, Jun Tian Wu, Wei Chang, Yahui Li, Can Shen, Jinghua Liu

This study identifies HSF4 as a prognostic marker and potential therapeutic target in colorectal cancer, showing its association with patient survival and immune status.

bioRxiv · Jun 25, 2025 · PreprintCancer Biology